lenalidomide fresenius kabi 25mg tvrdá tobolka
fresenius kabi s.r.o., praha ČeskÁ republika - 17180 lenalidomid - tvrdá tobolka - 25mg - lenalidomid
lenalidomide gedeon richter 15mg tvrdá tobolka
gedeon richter plc., budapešť maĎarsko - 17180 lenalidomid - tvrdá tobolka - 15mg - lenalidomid
lenalidomide gedeon richter 20mg tvrdá tobolka
gedeon richter plc., budapešť maĎarsko - 17180 lenalidomid - tvrdá tobolka - 20mg - lenalidomid
lenalidomide gedeon richter 25mg tvrdá tobolka
gedeon richter plc., budapešť maĎarsko - 17180 lenalidomid - tvrdá tobolka - 25mg - lenalidomid
lenalidomide gedeon richter 2,5mg tvrdá tobolka
gedeon richter plc., budapešť maĎarsko - 17180 lenalidomid - tvrdá tobolka - 2,5mg - lenalidomid
lenalidomide gedeon richter 5mg tvrdá tobolka
gedeon richter plc., budapešť maĎarsko - 17180 lenalidomid - tvrdá tobolka - 5mg - lenalidomid
lenalidomide gedeon richter 7,5mg tvrdá tobolka
gedeon richter plc., budapešť maĎarsko - 17180 lenalidomid - tvrdá tobolka - 7,5mg - lenalidomid
lenalidomide krka d.d. novo mesto (previously lenalidomide krka)
krka, d.d., novo mesto - lenalidomide hydrochloride monohydrate - multiple myeloma; lymphoma, follicular - imunosupresiva - multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indikován k léčbě dospělých pacientů s dříve neléčeným mnohočetným myelomem, kteří nejsou způsobilí pro transplantaci. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka d. novo mesto as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka d. novo mesto as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indikován k léčbě dospělých pacientů s dříve neléčeným mnohočetným myelomem, kteří nejsou způsobilí pro transplantaci. lenalidomide krka d. novo mesto in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. follicular lymphomalenalidomide krka d. novo mesto in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).
lenalidomid stada 10mg tvrdá tobolka
stada arzneimittel ag, bad vilbel array - 17180 lenalidomid - tvrdá tobolka - 10mg - lenalidomid
lenalidomid stada 15mg tvrdá tobolka
stada arzneimittel ag, bad vilbel array - 17180 lenalidomid - tvrdá tobolka - 15mg - lenalidomid